Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2008
07/10/2008WO2008081701A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
07/10/2008WO2008081581A1 Foxp3 peptide vaccine
07/10/2008WO2008081478A2 A chimeric promoter and a method thereof
07/10/2008WO2008081457A2 Methods of isolating cardiac stem cells, banking and uses thereof
07/10/2008WO2008081388A1 Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof
07/10/2008WO2008081275A1 A method for the production of biomass from plant differentiated tissue
07/10/2008WO2008081043A1 Method for preparing pancreatic beta cells starting from beta cell progenitors and beta cells thereby obtained
07/10/2008WO2008081035A1 Anti-tumor vaccine derived from normal chemically modified cells
07/10/2008WO2008080200A1 Process for obtaining stem cells
07/10/2008WO2008063472A3 Method for reducing protease activity in plant hydrolysate
07/10/2008WO2008063421A3 Biodegradable t-cell activation device and methods
07/10/2008WO2008061995A3 Genetic ablation of the prp gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals
07/10/2008WO2008039874A3 Cancer stem cell antigen vaccines and methods
07/10/2008WO2008027456A3 Methods, compositions and kits relating to antigen presenting tumor cells
07/10/2008WO2008004260A3 Bio-membrane for tissue regeneration
07/10/2008WO2007134050A8 Binding polypeptides with optimized scaffolds
07/10/2008WO2007103763A3 Methods for generating and using stem cell profiles
07/10/2008WO2001018173A3 Dominant negative neuropilin-1
07/10/2008US20080168588 DNA sequences from tcd genomic region of photorhabdus luminescens
07/10/2008US20080168586 Brassica Plant Comprising a Mutant Fatty Acid Desaturase
07/10/2008US20080168585 Transgenic drought and freeze resistant plants; crops with enhanced resistance to enviromental stresses
07/10/2008US20080168584 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility
07/10/2008US20080168583 Nucleic acid molecules and other molecules associated with plants
07/10/2008US20080168581 Transgenic disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism
07/10/2008US20080168580 Plastid Transit Peptides
07/10/2008US20080168579 Expression vector comprising nucleotide sequences coding polypeptide fusion comprising organelle targeting sequences; tissue targeted therapy; directed protein evolution
07/10/2008US20080168578 Protein kinase stress-related proteins and methods of use in plants
07/10/2008US20080168577 Signal transduction stress-related proteins and methods of use in plants
07/10/2008US20080168576 Plants and seeds of corn variety lh327
07/10/2008US20080168574 Nucleotide sequences coding tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders
07/10/2008US20080168572 Nanoarchaeum genome, Nanoarchaeum polypeptides and nucleic acids encoding them and methods for making and using them
07/10/2008US20080167728 Graft prosthesis, materials and methods
07/10/2008US20080167727 Graft prosthesis, materials and methods
07/10/2008US20080167716 Cartilage repair apparatus and method
07/10/2008US20080167458 Nucleotide sequences coding immunoglobulin specific to cell surface transmembrane receptor for use in diagnosis, prevention and treatment of cell proliferative disorders
07/10/2008US20080167446 Rgd-enriched gelatine-like proteins with enhanced cell binding
07/10/2008US20080167385 Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof
07/10/2008US20080167340 6-Aminoisoquinoline Compounds
07/10/2008US20080167291 Neurogenesis by modulating angiotensin
07/10/2008US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors
07/10/2008US20080167265 Modulation of fr-alpha expression
07/10/2008US20080167264 Materials and methods to inhibit hodgkin and reed sternberg cell growth
07/10/2008US20080167259 Incorporating polynucleotides encoding fusion proteins comprising CFTR peptide and DNA binding domain of transcriptional activator that binds to site on detectable gene into host cell ; gene expressing; drug screening, high throughput assay; enhances dimerization of CFTR protein; cystic fibrosis
07/10/2008US20080167254 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents
07/10/2008US20080167250 Method For Induction and Enhancement of Apoptosis In Tumor Cells
07/10/2008US20080167245 Novel metastasis suppressor gene on human chromosome 8
07/10/2008US20080167243 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges
07/10/2008US20080167242 Toll-like receptor agonists and antagonists and methods of use thereof
07/10/2008US20080167241 Mu-1, member of the cytokine receptor family
07/10/2008US20080167240 Albumin Fusion Proteins
07/10/2008US20080167239 Albumin Fusion Proteins
07/10/2008US20080167238 Albumin Fusion Proteins
07/10/2008US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies
07/10/2008US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
07/10/2008US20080167223 Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity
07/10/2008US20080167214 variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution
07/10/2008US20080167213 Subtilase Variants
07/10/2008US20080166808 Bioartificial liver system
07/10/2008US20080166807 Autologous progenitor stem cells of gastrointestinal origin
07/10/2008US20080166806 Using mutant chemokine, cytokine and/or growth factor conjugates to target immunoglobulin fragment to tumor cells; antiproliferative and antitumor agents
07/10/2008US20080166805 Culturing human cells and tissues in an N-glycolylneuraminic acid-free environment
07/10/2008US20080166804 Compostions and methods for growing human embryonic stem cells
07/10/2008US20080166803 Nucleotide sequences coding cyclic nucleotide-gated channels for use in idenntifying modulators for prevention and treatment of cardiovascular, respiratory, cell proliferative and nervous system disorders
07/10/2008US20080166802 Nucleotide sequences coding immunoglobulin heavy chain for use in prevention and teatment of inflammatory disorders
07/10/2008US20080166801 Using multicompartment apparatus, filters and suction to separate preferential cells from bodily fluids; point-of-care site for specimen collection
07/10/2008US20080166800 Method and medicament for inhibiting the expression of a given gene
07/10/2008US20080166799 Fluorescent protein
07/10/2008US20080166798 Trimerizing Polypeptides and Their Uses
07/10/2008US20080166797 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
07/10/2008US20080166785 Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
07/10/2008US20080166783 In vivo incorporation of unnatural amino acids
07/10/2008US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
07/10/2008US20080166767 Using immortalized cells comprising vector coding cytomegalo viral regulatory sequences to propagate immunoglobulins
07/10/2008US20080166766 Genetic incorporation of unnatural amino acids into proteins in mammalian cells
07/10/2008US20080166763 Human toll homologues
07/10/2008US20080166761 Nucleotide sequences coding dipeptide forming enzyme
07/10/2008US20080166760 Nucleotide sequences coding beta -N-acetylglucosaminidase for use in identifying modulators for prevention, inhibition and/or treatment of bacterial infections
07/10/2008US20080166759 Nucleotide sequences coding chimeric immunoglobulin comprising salvage receptor binding epitope for use as reporter in immunodiagnostic and immunotherapeutics
07/10/2008US20080166757 Chimeric polypeptide comprising phosphodiesterase and/or lipase A signal sequences for enhancing cytosolic protein transfer
07/10/2008US20080166756 Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited
07/10/2008US20080166754 Plant caffeic acid-3-O-methyltransferase homologs
07/10/2008US20080166751 Method of Analyzing Dynamics in the Differentiation of Vascular Endothelial Progenitor Cells
07/10/2008US20080166749 Fluorescent Protein Sensors of Post-Translational Modifications
07/10/2008US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells
07/10/2008US20080166736 Using signal protein as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders
07/10/2008US20080166732 Gene transfer vector comprising polymerase for use as diagnostic tool in cancer detection
07/10/2008US20080166731 Plant caffeic acid-3-O-methytransferase homologs
07/10/2008US20080166724 VEGF-Modulated Genes and Methods Employing Them
07/10/2008US20080166713 ATM related kinase, ATX, nucleic acids encoding same and methods of use
07/10/2008US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use
07/10/2008US20080166425 Suppressing cellular cyclin D1 overexpression; mantle cell lymphoma; activating glycogen synthase kinase 3 beta and I kappa B kinase phosphorylation and ubiquitination for proteasome degradation
07/10/2008US20080166414 Delivery particles having surface altering agent; transfection efficiency
07/10/2008US20080166412 Modulating in vivo and/or in vitro with cerium oxide nanoparticles; safe, low cost; neurodegenerative disorders; tissue regeneration
07/10/2008US20080166379 Prepared from autologous lymphoma cells transfected with emm55; for canines; the modified cancer cells are highly immunogenic to the host, yet show no toxic side effects
07/10/2008US20080166378 Death receptor sensitizing compounds and methods of use therefor
07/10/2008US20080166375 Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells
07/10/2008US20080166364 Conjugated to antibody; thrombospondin receptor targeting
07/10/2008US20080166360 Recombinant pollen protein for use in diagnosis, prevention and treatment of allergies
07/10/2008US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders
07/10/2008US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders